and growth factors, the inclusion of bovine serum albumin (BSA) increases the cost and adds xenogeneic components. Recently, Burridge et al. 4 described modifications to the GiWi method, including replacing B27-ins with recombinant human albumin and l-ascorbic acid 2-phosphate. They reported that albumin and l-ascorbic acid 2-phosphate are necessary for cardiomyocyte differentiation with high yield and purity.
We also simplified the GiWi protocol and developed an albuminfree cardiomyocyte differentiation platform (Supplementary Methods). First, we compared B27-ins (Supplementary Table 1 ) with other published recipes for cardiomyocyte differentiation 1, [5] [6] [7] [8] [9] and identified five commonly shared differentiation media supplements (transferrin, sodium selenite, progesterone, putrescine and BSA). RPMI containing these five components (5F) supported hPSC differentiation to cardiomyocytes: more than 90% of the cells expressed cardiac troponin T (90% cTnT + ), comparable to the purity of cardiomyocytes generated in RPMI/B27-ins (Fig. 1b) . Removal of transferrin (4F) also produced 90% cTnT + cells.
However, removal of BSA from 4F medium resulted in virtually no cardiomyocytes. Treatment with 12 µM CHIR99021 (CH) caused prolific cell death in the absence of BSA. However, 6 µM CH produced >90% cTnT + cells in the absence of albumin ( Fig. 1b and Supplementary Fig. 1a ). In addition, 2.5 µM IWP2 was sufficient to induce >90% cTnT + cells ( Supplementary  Fig. 1b) , which is lower than the 5 µM IWP2 required in the presence of BSA. Thus, in contrast to the observation of Burridge et al., we found that albumin is not necessary for cardiomyocyte differentiation and that in fact its presence diminishes activity of small-molecule agonists and antagonists of Wnt signaling. Basal RPMI lacking supplements supported hPSC differentiation to cardiomyocytes when we used the GiWi method ( Supplementary  Fig. 1c) . DMEM, DMEM/F12 and MEM also supported cardiomyocyte differentiation, but RPMI outperformed these media (Supplementary Fig. 1d ).
6 µM CH in albumin-free RPMI induced robust brachyury expression in hPSCs ( Fig. 1c and Supplementary Fig. 2 ). However, 1% BSA or human recombinant albumin (HRA) completely blocked brachyury expression at CH concentrations up to 6 µM, demonstrating Wnt activation induced by Gsk3-inhibitor treatment is more efficient in media lacking albumin. 30 µM CH induced brachyury expression in medium containing 1% HRA (Fig. 1c) .
This a lbumin-f re e GiWi (name d GiWi2) proto c ol produced 88-98% cTnT + cells with yields of greater than 10 6 cardiomyocytes/cm 2 in multiple human embryonic stem cell (hESC) and induced pluripotent stem cell (iPSC) lines (Supplementary Table 2 and Supplementary Fig. 3 ). The GiWi2 protocol was equally effective with cells maintained in E8 or mTeSR1 media (Supplementary Fig. 4 ). These cardiomyocytes exhibited spontaneous contraction for more than 8 months (Supplementary Video 1) .
These chemically defined, albumin-free conditions supported cardiac induction from hPSCs, as determined by cTnT (Fig. 1d) , cardiac troponin I (cTnI; Fig. 1e ), sarcomeric myosin heavy chain, a-actinin and Nkx2.5 expression ( Supplementary  Fig. 5 ). a-actinin showed clear Z-line localization (Fig. 1e) , and connexin-43 localized to cell-cell junctions (Fig. 1f) . The earliest wave-like spontaneous contractions were observed on day 7, and robust beating was observed by day 10 (Supplementary
Chemically defined, albumin-free human cardiomyocyte generation
To the Editor: Human pluripotent stem cell (hPSC)-derived cardiomyocytes are important tools for cardiovascular research and have substantial therapeutic potential. Several efficient di fferentiation strategies have been devised to generate cardiomyocytes from hPSCs 1 . Recently, we 2,3 and Burridge et al. 4 published defined, growth factorfree protocols for differentiating hPSCs to cardiomyocytes.
Our Gsk3 inhibitor and Wnt inhibitor (GiWi) method (Fig. 1a) applies two small molecules at precise developmental stages to sequentially promote mesoderm formation and cardiomyocyte specification 2, 3 . Although the medium-RPMI with B27-ins (B27 without insulin)-used in the GiWi protocol lacks animal sera
Videos 2 and 3).
A representative recording of a ventricularlike action potential is shown (Fig. 1g and Supplementary  Table 3 ). Cardiomyocytes also exhibited spontaneous Ca 2+ transients (Supplementary Fig. 6 ). After 60 d in albumin-free medium, cardiomyocytes generated using the GiWi2 protocol maintained expression of cTnT, a-actinin and connexin-43 ( Supplementary Fig. 7 and Supplementary Table 4) .
Differences between our study and the Burridge et al. 4 report, including the cell density at initiation of differentiation and the exposure windows for GiWi chemicals, may account for their finding that albumin is necessary for efficient cardiomyocyte differentiation. For example, we found that the optimal window for Gsk3-inhibitor treatment was from days 0 to 1 and for Wntinhibitor treatment was from days 3 to 5, whereas Burridge et al. applied the Gsk3 inhibitor from days 0 to 2 and the Wnt inhibitor from days 2 to 4. We also found that hPSC treatment with the 6 µM Gsk3-inhibitor concentration that Burridge et al. used caused substantial cell death after 2 d in albumin-free medium. However, reducing the CH concentration and/or treatment time in the absence of albumin permitted efficient mesendoderm induction without cytotoxicity.
We report an efficient, robust and defined cardiomyocyte differentiation protocol in the absence of albumin. The need to tune small-molecule presentation in the absence of albumin might have broader implications on development of other defined, small molecule-based stem cell differentiation systems.
